Basic Materials / Specialty ChemicalsLSE
$302.00
+1.00 (+0.33%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $15.4M · quality 55.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$178M
P/E
43.1x
↑EV/EBITDA
1434.6x
↑ROE
3.8%
↑Gross Margin
25.9%
↑Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-1.9%
FCF CAGR
—
FCF margin
4.8%
FCF / Net income
1.25x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $132.5M · net income $5.1M · FCF $6.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $132.5M | $132.5M | $150.2M | $147.4M | $140.2M |
| Net Income | $5.1M | $5.1M | $13.9M | $10.9M | $13.3M |
| EBITDA | $12.8M | $12.8M | $23.7M | $19.0M | $19.2M |
| EPS | 0.08 | 0.08 | 0.23 | 0.18 | 0.22 |
| Gross Margin | 25.9% | 25.9% | 29.3% | 30.4% | 27.9% |
| Operating Margin | 7.3% | 7.3% | 12.6% | 12.4% | 11.3% |
| Net Margin | 3.8% | 3.8% | 9.2% | 7.4% | 9.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.02 | 0.08 | 0.19 |
| Current Ratio | 3.39 | 3.39 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $6.3M | $6.3M | $15.4M | $15.8M | $-14.2M |
| Returns | |||||
| ROE | 3.8% | 3.8% | 9.8% | 8.0% | 9.9% |
| Valuation | |||||
| P/E | 43.14 | 43.14 | 1861.16 | 2456.73 | 2552.70 |
| EV/EBITDA | 1434.63 | 1434.63 | 1132.29 | 1416.72 | 1771.08 |
| P/B | 135.78 | 135.78 | 190.04 | 195.91 | 253.99 |
| Growth & Yield | |||||
| Revenue Growth | -11.8% | -11.8% | 1.9% | 5.1% | — |
| EPS Growth | -64.4% | -64.4% | 31.1% | -17.9% | — |
| Dividend Yield | 1.9% | 1.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
584.4%
EPS terminal req.
$26.80
Spread vs growth
-648.8%
5Y implied EPS CAGR
229.4%
EPS terminal req.
$32.42
Spread vs growth
-293.8%
10Y implied EPS CAGR
90.4%
EPS terminal req.
$52.22
Spread vs growth
-154.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+15.8%
Start / end P/E
1128.6x → 3612.4x
EPS bridge
0.23 → 0.08
Residual
-141.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.